Department of Orthopaedics and Sports Medicine, Morsani College of Medicine, Tampa, FL, USA.
Florida Orthopaedic Institute, Tampa, FL, USA.
J Shoulder Elbow Surg. 2019 May;28(5):900-907. doi: 10.1016/j.jse.2018.10.023. Epub 2019 Jan 25.
Patients with pain and disability due to a prior failed shoulder arthroplasty with associated proximal humeral bone loss have limited reconstruction options. Our purpose was to report the results of a large cohort of patients treated with a reverse shoulder allograft-prosthetic composite (APC).
Between 2002 and 2012, a total of 73 patients were treated with a reverse shoulder APC and had adequate follow-up. Clinical outcome scores, range of motion, and radiographic evidence of failure were assessed. The minimum follow-up period was 2 years, with an average of 67.9 months (range, 21-157 months). Of the patients, 43 had more than 5 years' follow-up and 12 had more than 10 years' follow-up.
The total American Shoulder and Elbow Surgeons score improved from 33.8 to 51.4 (P < .0001), and the Simple Shoulder Test score improved from 1.3 to 3.5 (P < .0001). Good to excellent results were reported in 42 of 60 patients (70%), 10 patients (17%) reported satisfactory results, and 8 patients (13%) were unsatisfied. Range of motion improved in forward flexion (49° to 75°, P < .001) and abduction (45° to 72°, P < .001). Revision was required in 14 patients (19%) for periprosthetic fracture (n = 6), instability (n = 2), glenosphere dissociation (n = 2), humeral loosening (n = 2), and infection (n = 2) at a mean of 38 months postoperatively. The reoperation-free survival rate of all reconstructions was 88% (30 of 34) at 5 years, 78% (21 of 27) at 10 years, and 67% (8 of 12) beyond 10 years. Ten patients had radiographic evidence of humeral loosening at final follow-up, and 2 required revision.
The use of a reverse total shoulder APC provides reliable pain relief and improved range of motion, with an acceptable rate of complications. Although ultimate function achieved is limited, patient satisfaction remains high.
患有疼痛和残疾的患者,其先前的肩关节置换术失败,并伴有肱骨头近端骨丢失,其重建选择有限。我们的目的是报告一组使用反向肩关节同种异体-假体复合材料(APC)治疗的大量患者的结果。
在 2002 年至 2012 年间,共有 73 例患者接受了反向肩关节 APC 治疗,随访时间足够。评估了临床结果评分、活动范围和影像学失败证据。最低随访时间为 2 年,平均随访时间为 67.9 个月(范围为 21-157 个月)。其中 43 例患者的随访时间超过 5 年,12 例患者的随访时间超过 10 年。
总的美国肩肘外科医生评分从 33.8 分提高到 51.4 分(P<.0001),简单肩部测试评分从 1.3 分提高到 3.5 分(P<.0001)。60 例患者中有 42 例(70%)报告结果良好或优秀,10 例(17%)报告满意,8 例(13%)不满意。前屈(49°至 75°,P<.001)和外展(45°至 72°,P<.001)的活动范围均有所改善。术后平均 38 个月时,14 例患者(19%)因假体周围骨折(n=6)、不稳定(n=2)、肱骨头脱位(n=2)、肱骨松动(n=2)和感染(n=2)需要翻修。所有重建的无再手术生存率在 5 年时为 88%(30/34),在 10 年时为 78%(21/27),在 10 年以上时为 67%(8/12)。10 例患者在最后一次随访时出现肱骨松动的影像学证据,其中 2 例需要翻修。
使用反向全肩关节 APC 可提供可靠的疼痛缓解和改善的活动范围,并发症发生率可接受。尽管最终功能有限,但患者满意度仍然很高。